Mylan announced the launch of Dutasteride Capsules, the generic version of GlaxoSmithKline‘s Avodart

Avodart is indicated as monotherapy for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to improve sypmtoms, reduce the risk of acute urinary retention, and reduce the risk of the need for BPH-related surgery. It may also be used in combination with tamsulosin for the treatment of symptomatic BPH in men with an enlarged prostate. 

Related Articles

Dutasteride, a 5 alpha-reductase inhibitor, inhibits the conversion of testosterone to dihydrotestosterone (DHT). DHT is the androgen primarily responsible for the initial development and subsequent enlargement of the prostate gland. Dutasteride is a competitive and specific inhibitor of both type 1 and type 2 5 alpha-reductase isoenzymes, with which it forms a stable enzyme complex.

Dutasteride Capsules are available in a 0.5mg strength. 

For more information call (800) RX-MYLAN or visit